06896.HK
Golden Throat Holdings Group Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 1.94
−0.51%Margins
Gross margin
74.4%
EBITDA margin
32.9%
EBIT margin
29.1%
Net margin
23.8%
FCF margin
8.6%
17.9%
Return on equity
10.1%
Return on assets
13.8%
Return on invested capital
0.41x
Asset turnover
HKD 144.1M
Cash from operations
HKD 1.71
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026